Future therapies for pancreatic carcinoma: Insights into cancer precision medicine

por Jiang, Qiu-Yu, Chen, Zhi-Xue, Zhang, Si, Xue, Ru-Yi
Publicado 2022

Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/Twist1 pathway

por Yin, Jie, Wang, Lan, Zhu, Ji-Min, Yu, Qian, Xue, Ru-Yi, Fang, Ying, Zhang, Yi-An, Chen, Yan-Jie, Liu, Tao-Tao, Dong, Ling, Shen, Xi-Zhong
Publicado 2016

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation

por Lin, Xia-Hui, Li, Dong-ping, Liu, Zhi-Yong, Zhang, Si, Tang, Wen-qing, Chen, Rong-xin, Weng, Shu-qiang, Tseng, Yu-jen, Xue, Ru-yi, Dong, Ling
Publicado 2023

Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study

por QU, LI-SHUAI, JIN, FEI, GUO, YAN-MEI, LIU, TAO-TAO, XUE, RU-YI, HUANG, XIAO-WU, XU, MIN, CHEN, TAO-YANG, NI, ZHENG-PING, SHEN, XI-ZHONG
Publicado 2016

circRanGAP1/miR-27b-3p/NRAS Axis may promote the progression of hepatocellular Carcinoma

por Lin, Xia-Hui, Liu, Zhi-Yong, Zhang, Dan-Ying, Zhang, Si, Tang, Wen-Qing, Li, Dong-Ping, Zhang, Feng, Chen, Rong-Xin, Weng, Shu-Qiang, Xue, Ru-Yi, Dong, Ling
Publicado 2022